BPG is committed to discovery and dissemination of knowledge
Articles Published Processes
7/26/2020 8:24:58 AM | Browse: 1084 | Download: 1768
 |
Received |
|
2020-02-26 11:56 |
|
Peer-Review Started |
|
2020-02-26 11:56 |
|
First Decision by Editorial Office Director |
|
2020-04-26 21:15 |
|
Return for Revision |
|
2020-04-26 21:15 |
|
Revised |
|
2020-05-09 14:22 |
 |
Publication Fee Transferred |
|
|
|
Second Decision by Editor |
|
2020-05-27 09:47 |
|
Second Decision by Editor-in-Chief |
|
|
|
Final Decision by Editorial Office Director |
|
2020-05-28 21:45 |
|
Articles in Press |
|
2020-05-28 21:45 |
|
Edit the Manuscript by Language Editor |
|
2020-06-05 05:49 |
|
Typeset the Manuscript |
|
2020-07-24 08:41 |
|
Publish the Manuscript Online |
|
2020-07-26 08:24 |
| ISSN |
1948-0210 (online) |
| Open Access |
This article is an open-access article that was selected by an in-house editor and fully peer-reviewed by external reviewers. It is distributed in accordance with the Creative Commons Attribution NonCommercial (CC BY-NC 4.0) license, which permits others to distribute, remix, adapt, build upon this work non-commercially, and license their derivative works on different terms, provided the original work is properly cited and the use is non-commercial. See: http://creativecommons.org/licenses/by-nc/4.0/ |
| Copyright |
© The Author(s) 2020. Published by Baishideng Publishing Group Inc. All rights reserved. |
| Article Reprints |
For details, please visit: http://www.wjgnet.com/bpg/gerinfo/247
|
| Permissions |
For details, please visit: http://www.wjgnet.com/bpg/gerinfo/207
|
| Publisher |
Baishideng Publishing Group Inc, 7041 Koll Center Parkway, Suite 160, Pleasanton, CA 94566, USA |
| Website |
http://www.wjgnet.com |
| Category |
Cell Biology |
| Manuscript Type |
Review |
| Article Title |
Potential of transposon-mediated cellular reprogramming towards cell-based therapies
|
| Manuscript Source |
Invited Manuscript |
| All Author List |
Dharmendra Kumar, Taruna Anand, Thirumala R Talluri and Wilfried A Kues |
| ORCID |
|
| Funding Agency and Grant Number |
|
| Corresponding Author |
Dharmendra Kumar, PhD, Senior Scientist, Animal Physiology and Reproduction Division, ICAR-Central Institute for Research on Buffaloes, Grass Farm Road, Hisar 125001, India. dharmendra.kumar@icar.gov.in |
| Key Words |
Transposons; Induced pluripotent stem cells; Clinical applications; Cellular reprogramming; Cell-based therapy; Genetic correction |
| Core Tip |
Seminal discovery of induced pluripotent stem (iPS) cells have opened up the possibility of converting most somatic cell types into a pluripotent state. The iPS cells possess most of the advantages of embryonic stem cells without the ethical stigma associated with derivation of the latter. This procedure has had a large impact on generation of custom-made pluripotent cells, ideal for cell-type specific differentiation and regenerative medicine with or without genetic correction. In this review, we focus on updated information of transposon system-mediated cellular reprogramming to iPS cells and their application in cellular therapy. |
| Publish Date |
2020-07-26 08:24 |
| Citation |
Kumar D, Anand T, Talluri TR, Kues WA. Potential of transposon-mediated cellular reprogramming towards cell-based therapies. World J Stem Cells 2020; 12(7): 527-544 |
| URL |
https://www.wjgnet.com/1948-0210/full/v12/i7/527.htm |
| DOI |
https://dx.doi.org/10.4252/wjsc.v12.i7.527 |
All content on this site: Copyright © 1993-2026 Baishideng Publishing Group Inc, its licensors, and contributors. All rights are reserved, including those for text and data mining, AI training, and similar technologies. For all open access content, the relevant licensing terms apply.
